Genetic Marker

Healio spoke with Karen L. Reckamp, MD, MS, medical director of clinical research operations, co-director of the thoracic oncology program, and professor in the department of medical oncology at City of Hope Comprehensive Cancer Center in Duarte, California, about her research in immunotherapy treatments for non-small cell lung cancer and the role of genetics to better target individual therapies for patients with lung cancer.

Genetic determinants of LDL levels may increase the risk for CVD among patients with hypercholesterolemia, according to a study published in JAMA Cardiology.